Skip to main content
Clinical Trials/NCT00002655
NCT00002655
Completed
Phase 2

Cryosurgical Destruction of Surgically Incurable Liver Tumors

University of Colorado, Denver1 site in 1 countryMarch 1995

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Liver Cancer
Sponsor
University of Colorado, Denver
Locations
1
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

RATIONALE: Cryosurgery kills cancer cells by freezing them during surgery.

PURPOSE: Phase I/II trial to study the effectiveness of cryosurgery in treating patients with unresectable primary liver cancer or liver metastases.

Detailed Description

OBJECTIVES: I. Assess the safety and efficacy of liquid nitrogen necrosis of liver lesions using a commercially available intraoperative cryosurgical system, with placement of the cryoprobe and subsequent monitoring by high-resolution ultrasound. II. Use this technique on selected patients with surgically unresectable metastatic or primary liver cancer whose disease appears confined to the liver and who are potentially curable if all tumor in the liver can be destroyed. III. Quantitate the quality and duration of survival, identify recurrence of hepatic malignant disease, and identify any morbidity from the procedure. OUTLINE: Cryosurgery. Liquid nitrogen freezing of tumor using a cryoprobe placed and maintained under ultrasound guidance. PROJECTED ACCRUAL: 50 patients will be treated.

Registry
clinicaltrials.gov
Start Date
March 1995
End Date
September 1999
Last Updated
12 years ago
Study Type
Interventional
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials